VERACYTE, INC.

Profile

Company Names

VERACYTE, INC.

Addresses

7000 SHORELINE COURT, SUITE 250, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 243-6300

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$22,108,951.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2014-09-16 
$12,797,283.00 
$12,797,283.00 
$0.00 
Equity 
1
2010-06-04 
$9,311,668.00 
$28,435,000.00 
$19,123,332.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BONNIE 
 
ANDERSON 
EXECUTIVE OFFICER, DIRECTOR
VERACYTE, INC.   |  CASTLE BIOSCIENCES INC   |  PINKDX, INC.
BONNIE 
H. 
ANDERSON 
EXECUTIVE OFFICER, DIRECTOR
VERACYTE, INC.
BRIAN 
 
ATWOOD 
DIRECTOR
IMMUNE DESIGN CORP.   |  VERACYTE, INC.   |  MIRINA CORP   |  FIVE PRIME THERAPEUTICS INC   |  GROOVE BIOPHARMA CORP   |  PHASERX, INC.   |  ATRECA, INC.   |  CELL DESIGN LABS, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
BRIAN 
G. 
ATWOOD 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  PHASERX INC   |  OPGEN INC   |  TRIUS THERAPEUTICS INC   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  VERSANT SIDE FUND II, LP   |  PHASERX, INC.   |  CLOVIS ONCOLOGY, INC.   |  VERACYTE, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
JULIE 
 
BROOKS 
EXECUTIVE OFFICER
VERACYTE, INC.   |  CUREVO, INC.
BROOK 
 
BYERS 
DIRECTOR
OPTIMEDICA CORP   |  HX DIAGNOSTICS INC   |  CRESCENDO BIOSCIENCE, INC.   |  CARDIODX INC   |  VERACYTE, INC.   |  FIVE PRIME THERAPEUTICS INC   |  XDX, INC.   |  ELCELYX THERAPEUTICS, INC.   |  FOUNDATION MEDICINE, INC.   |  OCULEVE, INC.   |  ENJOY TECHNOLOGY, INC.   |  ZEPHYR HEALTH, INC.   |  NEWSELA, INC.   |  CAREDX, INC.   |  CELL DESIGN LABS, INC.   |  GRAIL, INC.   |  OCTAVE BIOSCIENCE INC   |  EPIODYNE, INC.   |  ARSENAL BIOSCIENCES, INC.
BROOK 
H. 
BYERS 
DIRECTOR
KPCB DIGITAL GROWTH FUND, LLC   |  CARDIODX INC   |  VERACYTE, INC.
FRED 
 
COHEN 
DIRECTOR
PROTEOGENIX INC   |  NODALITY INC   |  NODALITY, INC.   |  QUINTILES TRANSNATIONAL HOLDINGS INC.   |  CARDIODX INC   |  VERACYTE, INC.   |  FIVE PRIME THERAPEUTICS INC   |  XDX, INC.   |  NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.   |  REVAL HOLDINGS INC   |  NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.   |  BNA CHICAGO LLC   |  NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.   |  ROKA BIOSCIENCE, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  AUXOGYN, INC.   |  CAREDX, INC.   |  PROGYNY, INC.   |  CELL DESIGN LABS, INC.   |  CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.   |  VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  ASKLEPIOS BIOPHARMACEUTICAL, INC.   |  VV ATREUS SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  ASCEND GENE + CELL THERAPIES LTD.   |  FIREFLY NEUROSCIENCE, INC.   |  KYVERNA THERAPEUTICS, INC.   |  ASCEND ADVANCED THERAPIES GROUP, INC.   |  OLLIN BIOSCIENCES, INC.
FRED 
E. 
COHEN 
DIRECTOR
VERACYTE, INC.
SAMUEL 
D. 
COLELLA 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  VERACYTE, INC.   |  FLUIDIGM CORP   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  ALEXZA PHARMACEUTICALS INC.   |  VERSANT SIDE FUND II, LP
DOUG 
 
DOLGINOW 
DIRECTOR
VERACYTE, INC.   |  GENOMEDX BIOSCIENCES INC.
KARIN 
 
EASTHAM 
DIRECTOR
TRIUS THERAPEUTICS INC   |  VERACYTE, INC.   |  VETICA LABS, INC.
SHELLY 
D. 
GUYER 
EXECUTIVE OFFICER
IRHYTHM TECHNOLOGIES INC   |  IRHYTHM TECHNOLOGIES, INC.   |  VERACYTE, INC.   |  NGM BIO HOLDINGS, INC.
EVAN 
 
JONES 
DIRECTOR
OPGEN INC   |  VERACYTE, INC.   |  CAS MEDICAL SYSTEMS INC   |  FOUNDATION MEDICINE, INC.   |  FLUIDIGM CORP   |  HELIUS MINERALS LTD
JONATHAN 
T. 
LORD 
DIRECTOR
VERACYTE, INC.   |  DEXCOM INC   |  VIGILANT BIOSCIENCES, INC.   |  DIGITAL REASONING SYSTEMS, INC.   |  BIOLASE, INC
JESSE 
 
TREU 
DIRECTOR
TANDEM DIABETES CARE INC   |  AFFERENT PHARMACEUTICALS, INC.   |  REGADO BIOSCIENCES INC   |  VERACYTE, INC.   |  ALTEA THERAPEUTICS CORP   |  RIGHTCARE SOLUTIONS, INC.   |  SEBACIA, INC.
JESSE 
I. 
TREU 
DIRECTOR
ALTEA THERAPEUTICS CORP   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  SOMAXON PHARMACEUTICALS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  VERACYTE, INC.   |  ALDEYRA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-09-30
D
Link
OTHER HEALTH CARE 
SERVICES-MEDICAL LABORATORIES [8071] 
$5,000,001 - $25,000,000 
Equity 
2014-09-16 
2010-06-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#